Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccine in Infants

BACKGROUND: Trivalent inactivated influenza vaccine (TIV) is not licensed for use in infants <6 months old, the group with the highest influenza hospitalization rates among children. METHODS: In this prospective, open-label study, 2 doses of TIV were administered to healthy infants aged 10–22 wee...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Halasa, Natasha B., Gerber, Michael A., Chen, Qingxia, Wright, Peter F., Edwards, Kathryn M.
Formato: Artigo
Idioma:Inglês
Publicado: 2008
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3773726/
https://ncbi.nlm.nih.gov/pubmed/18444800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/587643
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares